APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epidermal Growth Factor Receptor (EGFR) Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025187 pages

Choose your research edition.

Industry ResearchEpidermal Growth Factor Receptor (EGFR) Inhibitor Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Epidermal Growth Factor Receptor (EGFR) Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Epidermal Growth Factor Receptor (EGFR) Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epidermal Growth Factor Receptor (EGFR) Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epidermal Growth Factor Receptor (EGFR) Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Epidermal Growth Factor Receptor (EGFR) Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Epidermal Growth Factor Receptor (EGFR) Inhibitor include Novartis AG, Eli Lilly and Co., Amgen Inc., AstraZeneca Plc and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epidermal Growth Factor Receptor (EGFR) Inhibitor and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epidermal Growth Factor Receptor (EGFR) Inhibitor revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Epidermal Growth Factor Receptor (EGFR) Inhibitor market size, projected growth trends, production technologies, key applications, and end-use industries.

Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Company

Novartis AG

Eli Lilly and Co.

Amgen Inc.

AstraZeneca Plc

F. Hoffmann-La Roche Ltd.

Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Type

Colorectal Cancer

Lung Cancer

Breast Cancer

Others

Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Application

Clinic

Hospital

Research Institutes and Research Institutions

Other

Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epidermal Growth Factor Receptor (EGFR) Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epidermal Growth Factor Receptor (EGFR) Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Epidermal Growth Factor Receptor (EGFR) Inhibitor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Epidermal Growth Factor Receptor (EGFR) Inhibitor industry.

Chapter 3: Detailed analysis of Epidermal Growth Factor Receptor (EGFR) Inhibitor companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epidermal Growth Factor Receptor (EGFR) Inhibitorrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Colorectal Cancer Table 3. Key Players of Lung Cancer Table 4. Key Players of Breast Cancer Table 3. Key Players of Others Table 4. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinic Table 6. Key Players of Hospital Table 7. Key Players of Research Institutes and Research Institutions Table 8. Key Players of Other Table 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2021-2026) Table 12. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2027-2032) Table 14. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Trends Table 15. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Drivers Table 16. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Opportunities and Challenges Table 17. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Restraints Table 18. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Company (2021-2026) Table 20. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Company Head Office and Area Served Table 22. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Company, Product Type & Application Table 23. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2021-2026) Table 30. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2027-2032) Table 31. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2021-2026) Table 35. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2027-2032) Table 36. Novartis AG Company Information Table 37. Novartis AG Business Overview Table 38. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 40. Novartis AG Recent Development Table 41. Eli Lilly and Co. Company Information Table 42. Eli Lilly and Co. Business Overview Table 43. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 45. Eli Lilly and Co. Recent Development Table 46. Amgen Inc. Company Information Table 47. Amgen Inc. Business Overview Table 48. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 50. Amgen Inc. Recent Development Table 51. AstraZeneca Plc Company Information Table 52. AstraZeneca Plc Business Overview Table 53. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 55. AstraZeneca Plc Recent Development Table 56. F. Hoffmann-La Roche Ltd. Company Information Table 57. F. Hoffmann-La Roche Ltd. Business Overview Table 58. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 60. F. Hoffmann-La Roche Ltd. Recent Development Table 61. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 62. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 63. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 64. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 65. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 66. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) Table 67. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2027-2032) Table 68. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 69. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 70. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 71. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 72. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) Table 74. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2027-2032) Table 75. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 76. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 77. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 78. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 79. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 80. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 81. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 82. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) Table 85. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2027-2032) Table 86. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 87. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032) & (US$ Million) Table 88. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 89. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032) & (US$ Million) Table 90. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) Table 92. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2027-2032) Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Image Figure 2. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type: 2025 VS 2032 Figure 4. Colorectal Cancer Image Figure 5. Lung Cancer Image Figure 6. Breast Cancer Image Figure 7. Others Image Figure 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2025 VS 2032 Figure 10. Clinic Image Figure 11. Hospital Image Figure 12. Research Institutes and Research Institutions Image Figure 13. Other Image Figure 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2021-2032) Figure 23. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Application (2021-2032) Figure 25. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 26. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032) Figure 27. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032) Figure 28. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 29. United States Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 30. Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 32. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 33. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032) Figure 34. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032) Figure 35. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 36. Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 37. France Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 39. Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 40. Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 42. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 43. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032) Figure 44. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032) Figure 45. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 46. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032) Figure 47. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032) Figure 48. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 49. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 53. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 54. Australia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 59. Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 64. UAE Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 66. Chile Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Colorectal Cancer
  • Lung Cancer
  • Breast Cancer
  • Others
Applications
  • Clinic
  • Hospital
  • Research Institutes and Research Institutions
  • Other
Companies covered
  • Novartis AG
  • Eli Lilly and Co.
  • Amgen Inc.
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Colorectal Cancer
  5. 1.2.3 Lung Cancer
  6. 1.2.4 Breast Cancer
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Clinic
  11. 1.3.3 Hospital
  12. 1.3.4 Research Institutes and Research Institutions
  13. 1.3.5 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends by Region
  16. 1.5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2021-2026)
  18. 1.5.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Dynamics
  1. 2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Trends
  2. 2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Drivers
  3. 2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Opportunities and Challenges
  4. 2.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Company (2021-2026)
  2. 3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Company Head office and Area Served
  4. 3.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Company, Product Type & Application
  5. 3.5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Epidermal Growth Factor Receptor (EGFR) Inhibitor Tier 1, Tier 2, and Tier 3
4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Type
  1. 4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2032)
  3. 4.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2021-2032)
5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Application
  1. 5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2032)
  3. 5.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Eli Lilly and Co.
  8. 6.2.1 Eli Lilly and Co. Company Information
  9. 6.2.2 Eli Lilly and Co. Business Overview
  10. 6.2.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  12. 6.2.5 Eli Lilly and Co. Recent Developments
  13. 6.3 Amgen Inc.
  14. 6.3.1 Amgen Inc. Company Information
  15. 6.3.2 Amgen Inc. Business Overview
  16. 6.3.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  18. 6.3.5 Amgen Inc. Recent Developments
  19. 6.4 AstraZeneca Plc
  20. 6.4.1 AstraZeneca Plc Company Information
  21. 6.4.2 AstraZeneca Plc Business Overview
  22. 6.4.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  24. 6.4.5 AstraZeneca Plc Recent Developments
  25. 6.5 F. Hoffmann-La Roche Ltd.
  26. 6.5.1 F. Hoffmann-La Roche Ltd. Company Information
  27. 6.5.2 F. Hoffmann-La Roche Ltd. Business Overview
  28. 6.5.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
7 North America
  1. 7.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032)
  2. 7.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
  3. 7.2.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026)
  4. 7.2.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032)
  5. 7.2.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032)
  6. 7.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
  7. 7.3.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026)
  8. 7.3.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032)
  9. 7.3.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032)
  10. 7.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
  11. 7.4.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  13. 7.4.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2027-2032)
  14. 7.4.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032)
  2. 8.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
  3. 8.2.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026)
  4. 8.2.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032)
  5. 8.2.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032)
  6. 8.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
  7. 8.3.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026)
  8. 8.3.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032)
  9. 8.3.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032)
  10. 8.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
  11. 8.4.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  13. 8.4.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2027-2032)
  14. 8.4.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032)
  2. 9.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
  3. 9.2.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026)
  4. 9.2.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032)
  5. 9.2.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032)
  6. 9.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
  7. 9.3.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026)
  8. 9.3.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032)
  9. 9.3.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032)
  2. 10.2 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
  3. 10.2.1 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026)
  4. 10.2.2 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032)
  5. 10.2.3 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032)
  6. 10.3 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
  7. 10.3.1 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026)
  8. 10.3.2 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032)
  9. 10.3.3 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032)
  10. 10.4 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
  11. 10.4.1 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  13. 10.4.3 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2027-2032)
  14. 10.4.4 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst